Aigenpulse Strengthens Board with Appointment of Non-Executive Director
Mick Cross, Aigenpulse
Aigenpulse Ltd., a company at the forefront of employing data technologies and advanced machine learning to significantly reduce the time and money needed to create new drugs, announced the appointment of Mr Nicholas Cross as Non-Executive Director. He joins the company at an exciting stage in its development to help guide the scale-up of the business. Aigenpulse started in May 2016 and is already deploying its system with leading biotechs. They are growing rapidly in response to customer recognition of the value created.
The appointment is part of Aigenpulse’s strategy for growth in the biotech sector. The company’s scientific data management and advanced machine learning platform has been developed to help research-intensive organisations unlock the power of their data, create meaningful insights and make data-driven decisions.
Mr Cross was a co-founder of both Adaptimmune and Immunocore in 2008 and served the two as Chairman for five years. He was previously an investor in and non-executive director of Avidex from 2000 to 2006. His previous ventures have included Oxford Asymmetry Ltd (now part of Evotec) where he was a co-founder and Chairman for five years, Oxford Semiconductor Ltd (now part of Toshiba) where he was also a co-founder and first Chairman, Doctors.net (now part of M3 Corporation), Oxxon (now part of Oxford Biomedica), Lansdown Estates Group Ltd (now MEPC Milton Park Ltd.), and Oxagen Ltd.
Tobias Kloepper, Chief Executive Officer at Aigenpulse, said: “We are delighted to welcome Nick to Aigenpulse at this very exciting phase in our development. Nick is an exceptional serial-entrepreneur and we are looking forward to him applying his experience in building successful enterprises to help us create a unique company. Nick has taken companies from start-up to IPO and will add experience, wisdom and governance to the board.”
Nick Cross, non-executive director Aigenpulse, commented: “Science aided by ever-improving instruments is revealing the incredible complexity of living systems. Our understanding of this body of knowledge demands the finest analytical tools if we are to harvest its value. I believe Aigenpulse can give its users a competitive advantage in that regard and look forward to helping the company deliver.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.